News & Perspective

Oct 18, 2001

Oct 18, 2001

S pneumoniae resistance to macrolides is now common, CDC says

(CIDRAP News) – Macrolide antibiotics, the mainstay of treatment for community-acquired pneumonia, are encountering increasing resistance from Streptococcus pneumoniae, the most common cause of the disease, according to a report in the Oct 17 issue of the Journal of the American Medical Association.

Oct 25, 2001

Oct 25, 2001

Studies raise hopes for invention of drugs to block anthrax toxin

Oct 25 (CIDRAP News) – Two studies published online by Nature this week help explain how anthrax toxin works, possibly paving the way for the development of drugs that could block the toxin's action. One group of researchers explains how it identified the cell-surface receptor that enables anthrax toxin to invade host cells, while another group describes the precise molecular structure of a key component of the toxin.

Oct 26, 2001

Oct 26, 2001

In report on anthrax probe, CDC recommends multidrug treatment

(CIDRAP News) – The Centers for Disease Control and Prevention (CDC) gives a detailed report on its ongoing investigation of the current anthrax attack in today's issue of Morbidity and Mortality Weekly Report. The report includes a detailed treatment protocol for inhalational anthrax related to the current attack, calling for use of either ciprofloxacin or doxycycline plus one or two other antimicrobials.

Nov 02, 2001

Nov 02, 2001

Doxycycline, penicillin G procaine already approved for postexposure prophylaxis against anthrax, FDA notes

(CIDRAP News) – The Food and Drug Administration (FDA) published a notice in the Federal Register this week to make clear that doxycycline and penicillin G procaine, along with ciprofloxacin, already are approved for use as postexposure prophylaxis following inhalational exposure to anthrax. The notice also details postexposure dosing regimens for these medications.

Nov 05, 2001

Nov 05, 2001

Mayo Clinic and Roche announce 1-hour anthrax test

(CIDRAP New) – Officials from the Mayo Clinic and Roche Molecular Biochemicals today announced the development of a DNA test that they say can accurately detect anthrax bacteria in human and environmental samples in less than an hour, far faster than currently available tests. They said they will begin making the test available free to public health laboratories this week to help combat the current spate of anthrax attacks.

Nov 06, 2001

Nov 06, 2001

D. A. Henderson to direct new Office of Public Health Preparedness

(CIDRAP News) – Donald A. Henderson, MD, public health expert and director of the successful campaign to eradicate smallpox in the 1970s, has been appointed to coordinate the national response to public health emergencies. Tommy G. Thompson, secretary of the Department of Health and Human Services (HHS), named Henderson last week as director of the newly created Office of Public Health Preparedness.

Nov 07, 2001

Nov 07, 2001

CDC posting transcripts of media briefings on anthrax investigation

(CIDRAP News) – As part of its response to the recent anthrax attacks, the Centers for Disease Control and Prevention is holding daily media briefings on its anthrax investigation and related activities and posting transcripts of the briefings on its Web site.

Nov 08, 2001

Nov 08, 2001

CDC preparing teams to deal with smallpox threat

(CIDRAP News) – Teams of specialists at the Centers for Disease Control and Prevention have been vaccinated against smallpox and are training to respond to any intentional release of the smallpox virus, the CDC has announced.

Nov 12, 2001

Nov 12, 2001

Better antibiotics cited as top reason for improved survival in anthrax victims

Nov 12 (CIDRAP News) – Improved survival among victims of the recent anthrax attacks, as compared with past anthrax cases, is probably a result of better antibiotic regimens, early recognition and treatment, and improved supportive care, among other factors, according to Centers for Disease Control and Prevention (CDC) officials.

Nov 13, 2001

Nov 13, 2001

ACOG: When possible, use amoxicillin for anthrax prevention in pregnant women

(CIDRAP News) – Pregnant and lactating women who may have been exposed to anthrax should be treated prophylactically with amoxicillin rather than ciprofloxacin when the anthrax strain is found to be penicillin-sensitive, the American College of Obstetricians and Gynecologists (ACOG) recommends.

Pages

Sort Results

 

Narrow results

by Topic

by country

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»